Compare Otis Worldwide Corp (OTIS) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Otis Worldwide Corp vs TransMedics Group Inc — how do they compare? Otis Worldwide Corp trades at $70.74 (market cap $27.61B), while TransMedics Group Inc trades at $71.34 (market cap $2.57B). The key difference: Otis Worldwide Corp is far larger — about 10.7× TransMedics Group Inc's market cap, and Otis Worldwide Corp pays a 2.36% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| OTIS | TMDX | |
|---|---|---|
Market Cap | $27.61B | $2.57B |
Sector | Industrials | Technology |
52-Week High | $100.99 | $150.42 |
52-Week Low | $69.34 | $61.99 |
Enterprise Value | $34.99B | $2.97B |
Dividend Yield | 2.36% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Otis Worldwide Corp
Otis is the largest global elevator and escalator supplier by revenue with around one quarter of share excluding Japan. In 1854 Otis' founder and namesake, Elisha Graves Otis, invented a safety mechanism that prevented elevators from falling if the hoisting cable failed.The company's product and service lifecycle begins with installations of elevator units in new buildings, later selling maintenance services on the units, and eventually replacement of the units after the average 15-20 year useful life of an elevator. As the largest global OEM, over decades Otis has built a base of 2 million elevators under service. Its business model is much the same as that of its competitors Kone, Schindler, and Thyssenkrupp.
Read more on OTIS →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
